Evaluate the Outcomes of Ferric Carboxymaltose in Patients With Perioperative Anemia
A legfontosabb adatok
- Ki végzi
- Hospital Universitario Infanta Cristina
- Hol
- Spanyolország1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Befejeződött
- Résztvevők
- 152 fő vett részt
- Kezdés
- 2020. jan. 1.
- Befejezés
- 2024. dec. 31.
- A vizsgálat típusa
- Megfigyeléses, 2 csoport
- A vizsgált kezelések
- Ferric Carboxymaltose (FCM)
- A regiszteradat frissítve
- 2025. május 2.
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 5 feltétel megnézéseKevesebb
Ki vehet részt
- Age over 18 years; on the SWL
- Hemoglobine <13g/dL
- Referred for major elective surgery requiring hospital admission (e.g., oncologic resections such as mastectomy, colon resection, nephrectomy, hysterectomy), typically involving general anesthesia and moderate to high morbidity risk, capable of understanding and consenting to the study
- Physically and mentally able to complete assessments
Ki nem vehet részt
- Patients with hypersensitivity to FC, or any of its excipients. • Patients with active bleeding
Hol van ez a vizsgálat?
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
The prevalence of preoperative anaemia in patients undergoing major surgery is approximately 30%, and is independently associated with higher mortality, a higher rate of postoperative complications, and a greater probability of receiving a transfusion. In a prehabilitation program, the evaluation and correction of anaemia in the preoperative period is essential, as it is a risk factor for transfusions and complications. The main objectives of this study were to analyse the need for blood transfusion, post-surgical complications, hospital length of stay, ICU length of stay, hospital readmissions, and surgical wound infection in patients treated with ferric carboxymaltose (FC) before surgery. A total of 152 patients were included, of whom 96 received FC before the intervention and 56 received no treatment (control group).
A vizsgálat 2 csoportja
- Control (Not surgical prehabilitation)
This group received the standard preoperative patient assessment without going through a prehabilitation unit or undergoing any type of intervention. They did not receive this intervention because the surgical prehabilitation consultation had not yet been implemented at the hospital.
- Interventional group (Surgical prehabilitation)
This group received standardized care and assessments in a surgical prehabilitation consultation, including preoperative blood tests, correction of conditions such as anemia (including intravenous iron), and the necessary supplementation to optimize the patients.
Kezelés: Ferric Carboxymaltose (FCM)
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Evaluation of the Role of Preoperative Intravenous Iron in Patients Undergoing Surgery
- A regiszteradat frissítve
- 2025. május 2.